EPHs’ and ephrins’ aberrant expression characterize not only the tumor cells but also the tumor microenvironment, where endothelial cells have mostly been investigated; this makes the EPH/ephrin system an appealing candidate for targeted intervention [15,16,17,18,19,20]. This evidence concerns the gene EPHA1 and neoplasm.